Recent Posts by Enric Herrero

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications

Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer. The cell cycle research group of the Bellvitge Biomedical Research Institute (IDIBELL),…
Read more

RDKit conformation generation script

Conformer generation is one of the first and most important steps in most ligand based experiments, particularly when the ligand’s 3D structure is unknown. For example, the quality of the conformers could affect the results of virtual screening experiments. At Pharmacelera we have written a python script to generate conformations with RDKit1, one of the…
Read more

Pharmacelera selected as finalist in Pistoia Alliance Startup Challenge

Pharmacelera has been selected as one of the finalists of the Startup Challenge 2016 program organized by the Pistoia Alliance! This is an alliance from the pharmaceutical industry that is promoted by 8 of the top 10 pharma companies and other relevant service providers from the industry. As a result, Pharmacelera will perform a pitch…
Read more

Pharmacelera in BioSpain 2016

Pharmacelera has attended BIOSPAIN 2016 in Bilbao. BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+850). BIOSPAIN is organized by ASEBIO, the Spanish Bioindustry Association and each edition is co-organized by…
Read more

Recent Comments by Enric Herrero

No comments by Enric Herrero yet.